Charpentier, CharlotteBerzow, DirkHingrat, Quentin LeKaiser, RolfGomes, PerpétuaMiranda, Ana CláudiaDamond, FlorenceGhosn, JadeKampen, Jeroen J. A. vanJensen, Björn-Erik OleBöhm, MichaelWensing, Annemarie M. J.Descamps, DianeObermeier, Martin2026-05-112026-05-112025-09Charlotte Charpentier, Dirk Berzow, Quentin Le Hingrat, Rolf Kaiser, Perpetua Gomes, Ana Claudia Miranda, Florence Damond, Jade Ghosn, Jeroen J A van Kampen, Björn-Erik Ole Jensen, Michael Böhm, Annemarie M J Wensing, Diane Descamps, Martin Obermeier, HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update, Clinical Infectious Diseases, Volume 81, Issue 3, 15 September 2025, Pages 539–542, https://doi.org/10.1093/cid/ciaf1101537-6591http://hdl.handle.net/10400.26/63057Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.engHIV-2drug-resistance rulesInternet toolupdatecontribution to journal10.1093/cid/ciaf110